Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review

By afschroeder • October 23, 2026

Morad TT, Keykhaei M, Terraciano DA, Srivastava PK, Yang EH, Stein-Merlob AF. Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review. JACC CardioOncol. 2026 Oct;8(5):483-502. doi: 10.1016/j.jaccao.2026.09.003. PMID: 42904620.

Tags: arrhythmia, biomarkers, Cardiology/Epi, General Internal Medicine, heart failure, Hospitalist, immunotherapy, Myocarditis, Publications, Resident

Interrelationships Between Kansas City Cardiomyopathy Questionnaire Domains, Age, and Sex for Patients With Heart Failure: Findings From the CHAMP-HF and CORC Registries

Girard AA, Jones PG, Fu Z, Sherrod CF 4th, Cantu Martinez O, Greene SJ, Bachmann JM, Fonarow GC, Butler J, Spertus JA, Arnold SV. Interrelationships[...]

Patient-Level Perivascular Adipose Tissue Density Aggregation and Plaque Progression: Plaque-Free vs Plaque-Adjacent Segments

Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb I, Hadamitzky M, Kim[...]

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic Stroke

Royan R, Ikeaba U, Alhanti B, Stamm B, Mac Grory B, Prabhakaran S, Maas MB, Fonarow GC, Messe SR, Mamer LE, Goldstein JN, Saver JL,[...]